Comparative Anti-Obesity Activity of Probiotics with Short-Chain Fatty Acids (SCFAs) Through GLP 1 and PYY Activity in High Fat Diet Induces Obesity in Rats

Download Article

DOI: 10.21522/TIJPH.2013.12.03.Art007

Authors : P. Rajyalakshmi Devi, M. Vinyas, Vinod Kumar Nelson, Mote Srinath

Abstract:

Microbiota in the intestine produces SCFAs like Butyrate and Propionate through undigested fiber, which plays an important role in metabolic disorders, especially in obesity and type II diabetes. To compare the anti-obesity activity of probiotics with SCFAs through GLP-1 and PYY activity in HFD induced obesity in rats. For the study, rats weighing around 150-200g were chosen, separated into multiple groups, and given Fat-enriched diet for 12 weeks to trigger obesity. SCFAs like Butyrate, propionate (400mg/kg, P.O), and probiotics (108 CFU P.O) were continuously administered to their groups along with the HFD. Weekly once the animal's BW & daily food intake by the animal, and every 15 days once lipid profile, GLP, PYY, insulin, and leptin parameters were measured. After the completion of the study blood was collected through retro-orbital puncture for evaluation of biochemical parameters and animals were anesthetized and sacrificed for organ isolation for histopathological studies. Administration of SCFAs along with Probiotics in HFD-induced Overweight rats led to a notable drop in BW, food intake, fat accumulation, fasting insulin, leptin, and lipids throughout 12 weeks as compared with rats fed with HFD and standard. SCFAs along with probiotics effectively increase HDL levels and reduce LDL. Histopathology examination reveals that fat tissue accumulation was absent in treated groups when compared with only the HFD feed group. Results show that SCFAs are showing a notable decrease in lipid profile, food intake, and body weight than probiotics-treated group possesses significant anti-obesity activity.

References:

[1].   Bhutani, K. K., Birari, R., Kapat, K., 2007, Potential Anti-Obesity and Lipid Lowering Natural Products: A Review. Natural Product Communications,2(3). https://doi:10.1177/1934578X0700200316

[2].   Mopuri, R., Ganjayi, M., Banavathy, K. S., Parim, B. N., Meriga, B., 2015, Evaluation of Anti-Obesity Activities of Ethanolic Extract of Terminalia Paniculata Bark on High Fat Diet-Induced Obese Rats. BMC Complement Altern Med. Mar 24,15,76. https://doi:10.1186/s12906-015-0598-3

[3].   Yuan, H. -D., Kim, S. -J.; Quan, H.-Y., Huang, B., Chung, S. -H., 2010, Ginseng Leaf Extract Prevents High Fat Diet-Induced Hyperglycemia and Hyperlipidemia Through AMPK Activation. J. Ginseng Res. 34, 369–375. https://doi.org/10.5142/jgr.2010.34.4.369

[4].   Saravanan, G., Ponmurugan, P., Deepa, M. A., Senthilkumar, B., 2014, Anti-Obesity Action of Gingerol: Effect on Lipid Profile, Insulin, Leptin, Amylase and Lipase in Male Obese Rats Induced by a High-Fat Diet. J Sci Food Agric, Nov, 94(14), 2972-7. https://doi:10.1002/jsfa.6642

[5].   Jura, M., Kozak, L. P., 2016, Obesity and Related Consequences to Ageing, Age (Dordr). Feb;38(1):23. https://doi:10.1007/s11357-016-9884-3

[6].   Dietz, W. H., Baur, L. A., Hall, K., Puhl, R. M., Taveras, E. M., Uauy, R., Kopelman, P., 2015 Management of Obesity: Improvement of Health-Care Training and Systems for Prevention and Care. Lancet. Jun 20;385(9986):2521-33. https://doi:10.1016/S0140-6736(14)61748-7

[7].   Kaczmarczyk, M. M., Miller, M. J., 2012, The Health Benefits of Dietary Fiber: Beyond the Usual Suspects of Type 2 Diabetes Mellitus, Cardiovascular Disease and Colon Cancer. Metabolism: Clinical and experimental, 61(8), 1058–1066. https://doi.org/10.1016/j.metabol.2012.01.017

[8].   Edwards, C. A., Xie, C., Garcia, A. L., 2015, Dietary Fibre and Health in Children and Adolescents. Proc Nutr Soc. Aug;74(3):292-302. https://doi:10.1017/S0029665115002335

[9].   Liu, X., Wu, Y., Li, F., Zhang, D., 2015, Dietary Fiber Intake Reduces Risk of Inflammatory Bowel Disease: Result from a Meta-Analysis. Nutr Res. Sep,35(9),753-8. https://doi:10.1016/j.nutres.2015.05.021

[10]. Keenan, M. J, Zhou, J., Hegsted, M., Pelkman, C., Durham, H. A., Coulon, D. B., Martin, R. J., 2015 Role of Resistant Starch in Improving Gut Health, Adiposity, and Insulin Resistance. Adv Nutr, 6(2),198-205. https://doi:10.3945/an.114.007419

[11]. Anastasovska, J., Arora, T., et al. 2012, Fermentable carbohydrate Alters Hypothalamic Neuronal Activity and Protects Against the Obesogenic Environment, 20(5), 1016–1023. https://doi.org/10.1038/oby.2012.6

[12]. Wanders, A. J., van den Borne, J. J., et.al, 2011, Effects of Dietary Fibre on Subjective Appetite, Energy Intake and Body Weight: A Systematic Review of Randomized Controlled Trials, 12(9), 724–739. https://doi.org/10.1111/j.1467-789X.2011.00895.x

[13]. Tan, J., McKenzie, C., Potamitis, M., et.al. 2014, The Role of Short-Chain Fatty Acids in Health and Disease. Advances in Immunology, 121, 91–119. https://doi.org/10.1016/B978-0-12-800100-4.00003-9

[14]. Canfora, E. E., Jocken, J. W., & Blaak, E. E., 2015, Short-Chain Fatty Acids in Control of Bodyweight and Insulinsensitivity,11(10),577591.https://doi.org/10.1038/nrendo.2015.128

[15]. Tazoe, H., Otomo, Y., Karaki, S., Kato, I., Fukami, Y., Terasaki, M., & Kuwahara, A. 2009, Expression of Short-Chain Fatty Acid Receptor GPR41 in the Human Colon. Biomedical Research, 30(3), 149–156. https://doi.org/10.2220/biomedres.30.149

[16]. Samuel, B. S., Shaito, A., Motoike, T., et.al 2008, Effects of the Gut Microbiota on Host Adiposity are Modulated by the Short-Chain Fatty-Acid Binding G Protein-Coupled Receptor, Gpr41, 105(43), 16767–16772. https://doi.org/10.1073/pnas.0808567105

[17]. Nemet, I., et al. 2020, A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts Via Adrenergic Receptors.Cell,180(5),862–877.e22.https://doi.org/10.1016/j.cell.2020.02.016

[18]. Chaudhary, P. K., & Kim, S., 2021, An Insight into GPCR and G-Proteins as Cancer Drivers. Cells, 10(12), 3288. https://doi.org/10.3390/cells10123288

[19]. OECD 2008, Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264070684-en

[20]. Luna, L. G., 1968, Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. 3rd Edition, McGraw-Hill, New York.p. 258.

[21]. Kim, A., -Young & Jeong, et.al 2012, Dose Dependent Effects of Lycopene Enriched Tomato-Wine on Liver and Adipose Tissue in High-Fat Diet Fed Rats, 130. 42-48. https://doi.org/10.1016/j.foodchem.2011.06.050

[22]. BrahmaNaidu, P., et.al 2014, Mitigating Efficacy of Piperine in the Physiological Derangements of High Fat Diet Induced Obesity in Sprague Dawley Rats, 221, 42–51. https://doi.org/10.1016/j.cbi.2014.07.008

[23]. Shah, S. S., et.al 2011, Effect of Piperine in the Regulation of Obesity-Induced Dyslipidemia in High-Fat Diet Rats. Indian Journal of Pharmacology, 43(3), 296–299. https://doi.org/10.4103/0253-7613.81516

[24]. Johnson, R., McNutt, P., MacMahon, S., & Robson, R., 1997, Use of the Friedewald Formula to Estimate LDL-Cholesterol in Patients with Chronic Renal Failure on Dialysis. Clinical Chemistry, 43(11), 2183–2184.

[25]. Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P. K., & Lal, J., 2005, Effect of Mangiferin on Hyperglycemia and Atherogenicity in Streptozotocin Diabetic Rats, 97(3), 497–501. https://doi.org/10.1016/j.jep.2004.12.010

[26]. Suanarunsawat, T., et.al 2010, Antioxidant Activity and Lipid-Lowering Effect of Essential Oils Extracted from Ocimum Sanctum L. Leaves in Rats Fed with a High Cholesterol Diet. Journal of Clinical Biochemistry and Nutrition, 46(1), 52–59. https://doi.org/10.3164/jcbn.09-52

[27]. Kimura, I., et.al 2011, Short-Chain Fatty Acids and Ketones Directly Regulate Sympathetic Nervous System Via G Protein-Coupled Receptor 41 (GPR41), 108(19), 8030–8035. https://doi.org/10.1073/pnas.1016088108